These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7107370)

  • 41. Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro.
    Rockwell S
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1631-4. PubMed ID: 6434497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Misonidazole with small dose fractions in an experimental osteosarcoma.
    van Putten LM; Smink T
    Br J Cancer Suppl; 1978 Jun; 3():246-9. PubMed ID: 277240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the radiosensitizing effects of RK28 intravenous, intraarterial, and intratumoral injections on the rabbit VX2 tumor system.
    Ebe K; Suda H; Kuramitsu T; Honma Y; Nakanishi T; Miyata Y; Sakaguchi M; Matsunaga N
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1107-16. PubMed ID: 8985033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW; Morrissey S; Wolf K
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF; Bleehen NM; Ward R; Workman P
    Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):677-84. PubMed ID: 2843488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
    Workman P
    Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.
    Hill SA; Fowler JF
    Br J Cancer; 1977 Apr; 35(4):461-9. PubMed ID: 869984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
    McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA
    Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
    [No Abstract]   [Full Text] [Related]  

  • 50. Toxic and radiosensitizing effect of the 2-nitroimidazole misonidazole (Ro-07-0582) on murine CFU in vivo.
    Pettersen EO
    Br J Cancer Suppl; 1978 Jun; 3():107-10. PubMed ID: 277208
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Plasma and tissues distribution of misonidazole (RO 07-0582) in the rat bearing a chimio induced tumor (author's transl)].
    Akel G; Canal P; Bugat R; Soula G; Combes PF
    J Pharmacol; 1981; 12(4):383-91. PubMed ID: 7321570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response of an experimental mammary carcinoma to fractionated X-irradiation with misonidazole and microwave hyperthermia.
    Goldfeder A; Brown DM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1287-91. PubMed ID: 6469752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration.
    Hill SA; Fowler JF; Minchinton AI; Stratford MR; Denekamp J
    Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Aug; 44(2):143-50. PubMed ID: 6603435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
    Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo.
    Brown JM
    Radiat Res; 1977 Dec; 72(3):469-86. PubMed ID: 594322
    [No Abstract]   [Full Text] [Related]  

  • 56. Combinations of CCNU, MISO, and fractionated radiotherapy.
    Siemann DW; Alliet KL
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1379-82. PubMed ID: 3759559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of misonidazole (Ro-07-0582) on the incidence of micronuclei in irradiated Ehrlich tumour ascites cells.
    Olinici CD; Mustea I
    Int J Radiat Biol Relat Stud Phys Chem Med; 1978 Dec; 34(6):589-93. PubMed ID: 311764
    [No Abstract]   [Full Text] [Related]  

  • 58. [Development of new hypoxic cell radiosensitizer in Japan].
    Mori T; Murayama C
    Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
    Tada T; Nakajima T; Onoyama Y; Nagasawa H; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):688-90. PubMed ID: 1508643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N; Persky L
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.